Nia Therapeutics update: June 2021

  • Demonstrated proof of concept efficacy in patients with a history of traumatic brain injury
  • Completed development of our bench-top prototype and confirmed its cybersecurity architecture with FDA
  • Received a $1M subcontract from US Army and expanded our engineering team
  • Graduated from the Creative Destruction Lab accelerator and won the INVEST Precision Medicine pitch competition

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dan Rizzuto

Dan Rizzuto

CEO at Nia Therapeutics. Developing neural interfaces to restore memory after brain injury.